Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H18NO2.Cl |
Molecular Weight | 195.687 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].COC(=O)CCC[N+](C)(C)C
InChI
InChIKey=RZMKWKZIJJNSLQ-UHFFFAOYSA-M
InChI=1S/C8H18NO2.ClH/c1-9(2,3)7-5-6-8(10)11-4;/h5-7H2,1-4H3;1H/q+1;/p-1
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/16543627Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/22171995 and http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1602
Sources: http://www.ncbi.nlm.nih.gov/pubmed/16543627
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/22171995 and http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1602
Carpronium chloride is a hair growth reagent with a vasodilatory action. In vivo studies indicated that carpronium chloride achieved dilatation of vascular smooth muscle in the microcirculation of rats. FUROZIN SOLUTION 5% (active ingredient Carpronium chloride) has local vasodilating effect and hair growth stimulatory effect to improve alopecia and vitiligo. It is usually used for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01175 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | FUROZIN SOLUTION 5% Approved UseUsed for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris. |
|||
Primary | FUROZIN SOLUTION 5% Approved UseUsed for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris. |
|||
Primary | FUROZIN SOLUTION 5% Approved UseUsed for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris. |
PubMed
Title | Date | PubMed |
---|---|---|
Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies. | 2002 Oct |
|
Study of active substances involved in skin dysfunction induced by crowding stress. I. Effect of crowding and isolation on some physiological variables, skin function and skin blood perfusion in hairless mice. | 2003 Feb |
|
Effects of carpronium chloride on the microvascular blood flow in rat mesentery using intravital videomicroscopy. | 2006 |
|
Topical immunotherapy in alopecia areata. | 2010 Jan |
Patents
Sample Use Guides
For alopecia and seborrhea sicca:
In general, apply appropriate amount of the medicine to the affected area; or sprinkle the medicine on the whole scalp; twice to 3 times daily, and gently massage the head.
For vitiligo vulgaris:
In general, apply appropriate amount of the medicine to the affected area, 3 to 4 times daily.
Route of Administration:
Topical
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1896433
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
31362
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
C77850
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
m103
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | Merck Index | ||
|
236-243-6
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
100000081347
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
2839
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
25804
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
CARPRONIUM CHLORIDE
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
13254-33-6
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
1R01BKB74A
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
DTXSID1046924
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY | |||
|
SUB06145MIG
Created by
admin on Fri Dec 15 16:14:39 GMT 2023 , Edited by admin on Fri Dec 15 16:14:39 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD